Bridging the gap between study outcomes and real-world results. Algorithm-driven management in a rural cardioMEMS population

Published: March 7, 2025
Abstract Views: 149
PDF: 14
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Current therapeutic strategies are ineffective at keeping heart failure patients out of hospital. In 2017, all-cause readmission rates were 19.9% at thirty-days and 34.6% at ninety-days. Large scale studies have shown potential advantages with remote pulmonary artery pressure monitoring. We sought to refine the management of our remotely monitored cohort by introducing a hemodynamic treatment algorithm. A population of rural heart failure patients previously implanted and managed with remote pulmonary artery pressure sensors were studied (n=43). Algorithm based hemodynamic management began with prospective outcome monitoring for ninety days during which algorithm use was mandatory. Following the initial observation period, some physicians reverted to prior practice habit which included consideration of standard heart failure metrics into decision making. Following a six-month washout period, retrospective analysis was performed in evaluation of the intervention arm (n=34), patients managed by hemodynamic plus usual heart failure data, and the control group (n=30), those who remained strictly managed by algorithm. Pre-algorithm thirty-day heart failure specific hospitalization (HFH) rate was 60%. Algorithm-driven management decreased HFH rates to 19% at thirty-days and 12% at ninety-days. Incorporating standard heart failure metrics with remotely pulmonary artery (PA) pressure data markedly increased risk of readmission (7% vs 13% at thirty-days and 13% vs 42% at ninety-days). Heart failure patients managed via remote pulmonary artery pressures benefitted from algorithm-driven hemodynamic therapies. Utility and effectiveness of remote PA monitoring is stunted with consideration of traditional heart failure metrics (weights, symptoms, exam findings) in their management.

 

Graphical Abstract

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

1. Bozkurt B, Ahmad T, Alexander KM, et al. Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America. J Card Fail 2023;29:1412-51. DOI: https://doi.org/10.1016/j.cardfail.2023.07.006
2. Khan MS, Sreenivasan J, Lateef N, et al. Trends in 30- and 90-day readmission rates for heart failure. Circ Heart Fail 2021;14:e008335. DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.121.008335
3. Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011;377:658-66. DOI: https://doi.org/10.1016/S0140-6736(11)60101-3
4. Lindenfeld J, Costanzo MR, Zile MR, et al. Implantable hemodynamic monitors improve survival in patients with heart failure and reduced ejection fraction. J Am Coll Cardiol 2024;83:682-94. DOI: https://doi.org/10.1016/j.jacc.2023.11.030
5. Adamson PB, Abraham WT, Bourge RC, et al. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Circ Heart Fail 2014;7:935-44. DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.113.001229
6. Zile MR, Mehra MR, Ducharme A, et al. Hemodynamically-guided management of heart failure across the ejection fraction spectrum: The GUIDE-HF Trial. JACC Heart Fail 2022;10:931-44. DOI: https://doi.org/10.1016/j.jchf.2022.08.012
7. Ellison DH. Clinical pharmacology in diuretic use. Clin J Am Soc Nephrol 2019;14:1248-57. DOI: https://doi.org/10.2215/CJN.09630818
8. Valika A, Sulemanjee N, Pedersen R, Heidenreich D. Reduction in 90 day readmission rates utilizing ambulatory pulmonary pressure monitoring. ESC Heart Fail 2022;10:685-90. DOI: https://doi.org/10.1002/ehf2.14253
9. Angermann CE, Assmus B, Anker SD, et al. Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF). Eur J Heart Fail 2020;22:1891-901. DOI: https://doi.org/10.1002/ejhf.1943
10. Gupta DM, Richard J. Boland J, Aron DC. The physician’s experience of changing clinical practice: a struggle to unlearn. Implement Sci 2017;12:28. DOI: https://doi.org/10.1186/s13012-017-0555-2
11. Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med 2011;104:510-20. DOI: https://doi.org/10.1258/jrsm.2011.110180
12. Birken SA, Bunger AC, Powell BJ, et al. Organizational theory for dissemination and implementation research. Implement Sci 2017;12:62. DOI: https://doi.org/10.1186/s13012-017-0592-x
13. Edmondson AC, Lei Z. Psychological safety: the history, renaissance, and future of an interpersonal construct. Annu Rev Organ Psychol Organ Behav 2014;1:23-43. DOI: https://doi.org/10.1146/annurev-orgpsych-031413-091305
14. Ahmad T, Jackson K, Rao VS, et al. Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury. Circulation 2018;137:2016-28. DOI: https://doi.org/10.1161/CIRCULATIONAHA.117.030112
15. Maulion C, Chen S, Rao VS, et al. Hemoconcentration of creatinine minimally contributes to changes in creatinine during the treatment of decompensated heart failure. Kidney360 2022;3:1003-10. DOI: https://doi.org/10.34067/KID.0007582021
16. Emmens JE, Maaten JM ter, Matsue Y, et al. Worsening renal function in acute heart failure in the context of diuretic response. Eur J Heart Fail 2022;24:365-74. DOI: https://doi.org/10.1002/ejhf.2384
17. Hernandez AF, Greiner MA, Fonarow GC, et al. Relationship between early physician follow-up and 30-day readmission among medicare beneficiaries hospitalized for heart failure. JAMA 2010;303:1716–1722. DOI: https://doi.org/10.1001/jama.2010.533
18. Briasoulis A, Kishino Y, Kuno T, Malik A. Pulmonary artery pressure-guided therapy in patients with heart failure using the CardioMEMS device and HF readmissions: analysis of the National Readmissions Database. Eur Heart J 2022;43:ehac544.807. DOI: https://doi.org/10.1093/eurheartj/ehac544.807
19. Abraham WT, Adamson PB, Costanzo MR, et al. Hemodynamic monitoring in advanced heart failure: results from the LAPTOP-HF Trial. J Cardiac Fail 2016;22:940. DOI: https://doi.org/10.1016/j.cardfail.2016.09.012
20. Brugts JJ, Radhoe SP, Clephas PRD, et al. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial. Lancet 2023;401:2113-23. DOI: https://doi.org/10.1016/S0140-6736(23)00923-6
21. Lindenfeld J, Zile MR, Desai AS, et al. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Lancet 2021;398:991-1001. DOI: https://doi.org/10.1016/S0140-6736(21)01754-2
22. Thohan V, Abraham J, Burdorf A, et al. Use of a pulmonary artery pressure sensor to manage patients with left ventricular assist devices. Circ Heart Fail 2023;16:e009960. DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.122.009960

How to Cite

Atzenhoefer, M., Dille, E., Steinke, R., Weigert, N., Sabel, K., & Rasmussen, K. (2025). Bridging the gap between study outcomes and real-world results. Algorithm-driven management in a rural cardioMEMS population. Global Cardiology. https://doi.org/10.4081/cardio.2025.63

Similar Articles

<< < 1 2 3 4 5 > >> 

You may also start an advanced similarity search for this article.